Literature DB >> 14365591

Drugs affecting psychotic behavior and the function of the mesodiencephalic activating system.

F RINALDI, H E HIMWICH.   

Abstract

Entities:  

Keywords:  ANXIETY/therapy; CHLORPROMAZINE/therapeutic use; DIENCEPHALON/effect of drugs on; PSYCHOSES/therapy; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh:

Substances:

Year:  1955        PMID: 14365591

Source DB:  PubMed          Journal:  Dis Nerv Syst        ISSN: 0012-3714


× No keyword cloud information.
  9 in total

1.  [Pharmacological effects in mental disorders].

Authors:  E B TRUITT
Journal:  Klin Wochenschr       Date:  1959-06-01

2.  EXPERIMENTAL CENTRAL NERVOUS SYSTEM STUDIES RELATED TO ANAESTHESIA: CLINICAL IMPLICATIONS. I. ANAESTHESIA AND THE BRAIN STEM RETICULAR FORMATION. II. EFFECT OF REDUCED SENSORY INFLOW ON ANAESTHETIC REQUIREMENTS.

Authors:  L C JENKINS; G M LING; J G FOULKS; G S PENROSE
Journal:  Can Anaesth Soc J       Date:  1963-11

3.  On the psychology of the shaking palsy.

Authors:  W R FLYNN
Journal:  Psychiatr Q       Date:  1962-04

4.  The response of chronically hospitalized, lobotomized patients to treatment with chlorpromazine and reserpine.

Authors:  A A KURLAND; T G WILLIAMS; T E HANLON
Journal:  Psychiatr Q       Date:  1959-10

5.  Testing some implications of the sensory physiological model of the time sense.

Authors:  P A Vroon; A van Boxtel
Journal:  Psychol Forsch       Date:  1972

6.  The EEG of the olfactory bulb of the rabbit and its reaction to psychopharmacological agents.

Authors:  N Khazan; I Kandalaft; F G Sulman
Journal:  Psychopharmacologia       Date:  1967

7.  Centrally acting muscle relaxants in tetanus.

Authors:  R A WEBSTER
Journal:  Br J Pharmacol Chemother       Date:  1961-12

8.  Effects of general depressant drugs on the electrical responses of isolated slabs of cat's cerebral cortex.

Authors:  G B Frank; K Jhamandas
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

9.  1-Hydroxy-3-amino-pyrrolidone-2(HA-966): a new GABA-like compound, with potential use in extrapyramidal diseases.

Authors:  I L Bonta; C J De Vos; H Grijsen; F C Hillen; E L Noach; A W Sim
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.